The veterinary biologics market is growing rapidly. New vaccines, immunotherapies, and animal health biologics are transforming disease prevention and treatment across livestock, poultry, aquaculture, and companion animal sectors.

100ml PP vaccine vial

While much attention is focused on formulation development, the packaging system can have a significant impact on product performance and commercial success.

For biologics, not every bottle is suitable.

The Unique Challenges of Veterinary Biologics

Biologics differ from traditional veterinary pharmaceuticals because they contain highly sensitive biological materials.

These products may be vulnerable to:

Moisture

Oxygen

Light

Temperature variation

Surface interactions

As a result, packaging selection becomes a critical part of product development.

A packaging system that works well for conventional veterinary drugs may not be suitable for advanced biologics.

Packaging Must Support Product Stability

The primary purpose of biologic packaging is preserving product integrity throughout its lifecycle.

Manufacturers should consider:

Chemical compatibility

Barrier performance

Extractables and leachables risk

Closure integrity

Long-term stability

Failure to address these factors may result in potency loss or reduced shelf life.

Glass vs Plastic Packaging

Traditionally, glass has dominated vaccine packaging.

However, many veterinary manufacturers are now evaluating pharmaceutical-grade plastic containers because they offer:

Lower breakage risk

Reduced transportation costs

Better impact resistance

Improved handling safety

The optimal choice depends on formulation characteristics, distribution requirements, and regulatory considerations.

Supply Chain Reliability Matters

Packaging shortages can delay product launches and disrupt vaccine supply.

Veterinary biologic manufacturers should seek suppliers capable of providing:

Stable production capacity

Consistent quality systems

Long-term supply support

Global logistics capability

injection vial

A reliable packaging partner helps reduce operational risk and supports future growth.

Future-Proofing Your Biologics Portfolio

Animal health innovation continues to accelerate.

Products under development today may require:

Improved barrier performance

Advanced closure systems

Ready-to-fill packaging

Enhanced automation compatibility

Selecting the right packaging platform early can simplify future product expansion and regulatory submissions.

Conclusion

For veterinary biologics, packaging is more than a container—it is part of the product itself.

Manufacturers that carefully evaluate bottle materials, closure systems, stability requirements, and supplier capabilities are better positioned to bring reliable biologic products to market while maintaining quality throughout the supply chain.